PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue.
Vantler
Marius
M
Klinik III für Innere Medizin, Universität zu Köln, Germany.
Karikkineth
Bijoy Chandapillai
BC
Naito
Hiroshi
H
Tiburcy
Malte
M
Didié
Michael
M
Nose
Monika
M
Rosenkranz
Stephan
S
Zimmermann
Wolfram-H
WH
D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis; D000077214:Becaplermin; D049109:Cell Proliferation; D002867:Chromones / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006321:Heart / Q000502:physiology; D009025:Morpholines / Q000494:pharmacology; D009200:Myocardial Contraction; D032383:Myocytes, Cardiac / Q000378:metabolism*; D010649:Phenylalanine / Q000737:chemistry; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D020574:Proto-Oncogene Proteins c-sis; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D023822:Tissue Engineering / Q000379:methods
D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D010649:Phenylalanine